Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study

Early Onset Parkinson Disease Clinical Trial

Official title: Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study

Status Recruiting

Clinical Trial Summary

This study is designed to examine L. plantarum PS128 can improve symptoms in early onset PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with early onset PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Early Onset Parkinson Disease
• Parkinson Disease

• NCT number: NCT04722198
• Study type: Interventional
• Source: Professor Lu Neurological Clinic
• Contact: Chin-Song Lu, MD
• Phone: 886-3-3960388
• Email: cslu.public@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: October 27, 2020
• Completion date: December 31, 2021